|
|
|||||||
 |
|
|
LinkBack | Thread Tools | Display Modes |
07-31-2010, 04:35 PM
|
|||
|
|||
Genentech Team Uses Hybrid Approach to ID Novel Somatic Mutations, Potential Drug Tar
Researchers from Genentech , Affymetrix, and Pennsylvania State University have used a variety of methods, including mismatch repair detection technology, sequencing on Roche's 454 GS FLX, and array-CGH, to identify more than 2,500 somatic mutations in approximately 1,500 coding genes from 441 breast, lung, ovarian, and prostate cancer tumors.
    
|
|
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Thread Starter | Forum | Replies | Last Post |
| Cancer drug points way to new Alzheimer's approach | cancerfr | Skin Cancer | 0 | 09-02-2010 10:56 PM |
| A potential chemotherapeutic drug to treat hepatocellular carcinoma | cancerfr | Adrenocortical Carcinoma | 0 | 07-31-2010 04:35 PM |
| New Approach Developed to Improve Drug Delivery in Tumors | cancerfr | Extracranial Germ Cell Tumor | 0 | 07-19-2010 06:41 PM |
| Potential Cancer Drug Derived from Rainforest | cancerfr | Head and Neck Cancer | 0 | 06-14-2010 03:56 PM |
| Potential cancer drug derived from Australian rainforest | cancerfr | Head and Neck Cancer | 0 | 06-14-2010 03:56 PM |
Linear Mode
